Abstract
Stress‐induced apoptosis is mediated primarily through the intrinsic pathway that involves caspase‐9. We previously reported that in caspase‐9‐deficient cells, a protein complex containing ATG5 and Fas‐associated death domain (FADD) facilitated caspase‐8 activation and cell death in response to endoplasmic reticulum (ER) stress. Here, we investigated whether this complex could be activated by other forms of cell stress. We show that diverse stress stimuli, including etoposide, brefeldin A and paclitaxel, as well as heat stress and gamma‐irradiation, caused formation of a complex containing ATG5‐ATG12, FADD and caspase‐8 leading to activation of downstream caspases in caspase‐9‐deficient cells. We termed this complex the ‘stressosome’. However, in these cells, only ER stress and heat shock led to stressosome‐dependent cell death. Using in silico molecular modelling, we propose the structure of the stressosome complex, with FADD acting as an adaptor protein, interacting with pro‐caspase‐8 through their respective death effector domains (DEDs) and interacting with ATG5‐ATG12 through its death domain (DD). This suggests that the complex could be regulated by cellular FADD‐like interleukin‐1β‐converting enzyme–inhibitory protein (cFLIPL), which was confirmed experimentally. This study provides strong evidence for an alternative mechanism of caspase‐8 activation involving the stressosome complex.
Keywords: apoptosis, autophagy, caspase, cell stress, integrated stress response
1. INTRODUCTION
Caspase‐8 is a cysteine protease that was first identified as the apical caspase in the induction of extrinsic apoptosis.1 Since then, a role for caspase‐8 has emerged in diverse cellular processes in cancer biology and anticancer therapies, such as necroptosis,2 autophagy‐dependent cell death,3 inflammation and cytokine release,4 angiogenesis,5 cell adhesion and migration6 and immune cell homeostasis.7 Thus, caspase‐8 is important for tumour development, progression, therapy resistance and the development of the tumour microenvironment.
Pro‐caspase‐8 comprises a pro‐domain at the N‐terminus containing tandem death effector domains (DED1 and DED2), connected to a long domain and a short domain at the C‐terminus.8 The canonical mechanism of caspase‐8 activation during initiation of extrinsic (or death receptor‐mediated) apoptosis is through ligand‐induced oligomerization of death receptors (DR) such as Fas or tumour necrosis factor–related apoptosis‐inducing ligand receptors.8 This leads to recruitment of Fas‐associated death domain (FADD), which forms homotypic interactions with the DRs through their respective death domains (DDs) and with pro‐caspase‐8 through their respective DEDs. Together these form the death‐inducing signalling complex where caspase‐8 undergoes proximity‐induced auto‐activation.8
Several non‐canonical or alternative platforms for activation of caspase‐8 have been identified, many of which demonstrate a requirement for FADD as an adaptor protein.3, 9, 10, 11 Several studies describe an involvement of components of the autophagy pathway such as p623 or ATG5,3, 9, 10 while some report a role for autophagosomal membranes.3, 12, 13 Furthermore, unmitigated endoplasmic reticulum (ER) stress has been shown to activate caspase‐8 by inducing ligand‐independent intracellular DR5 activation, which is regulated by the integrated stress response (ISR) mediator, CHOP.14 We reported that caspase‐9 deficiency and blockade of the intrinsic apoptosis pathway can unmask an alternative caspase‐8‐dependent cell death pathway in response to ER stress. This caspase‐8 activation was independent of external DR ligation, but required interaction with FADD and ATG5 to form an intracellular caspase‐8‐activating complex.10
Here, we investigated whether ER stress is a unique inducer of the ATG5‐ATG12:FADD:pro‐caspase‐8 complex formation in caspase‐9‐deficient cells or whether it can assemble as a result of other cellular stresses. We demonstrate that in Casp9 −/− cells, a range of stress stimuli can activate caspase‐8 through the formation of a ATG5‐ATG12:FADD:pro‐caspase‐8 complex, which we termed the stressosome. Using molecular modelling, we generated a model supporting the interaction of caspase‐8 with FADD and interaction of the DD region of FADD with ATG5‐ATG12. Caspase‐8 activation required ATG5 but was independent of autophagy. Although activation of the ISR was a common feature of the various stress stimuli, it did not mediate pro‐caspase‐8 activation. We further demonstrated that stressosome‐induced activation of caspase‐8 was inhibited by cellular FLICE‐inhibitory protein (cFLIP).
2. MATERIALS AND METHODS
2.1. Cell culture and treatments
Caspase‐9‐deficient mouse embryonic fibroblasts (Casp9 −/− MEFs) and matched Casp9 +/+ MEFs were kindly gifted by Prof. Tak Mak (University of Toronto, Canada). Cells were cultured in high‐glucose Dulbecco's modified Eagle's medium (DMEM) (Sigma‐Aldrich, Saint Louis, Missouri, USA, D6429) supplemented with heat‐inactivated 10% (v/v) foetal bovine serum (FBS) (Sigma‐Aldrich, F7524), 100 U/ml penicillin, 100 mg/ml streptomycin (Sigma‐Aldrich, P0781), 2 mM L‐glutamine (Sigma‐Aldrich, G7513), non‐essential amino acids (Sigma‐Aldrich, M7145) and sodium pyruvate (Sigma‐Aldrich, S8636). Human embryonic kidney HEK 293T cells (ATCC, CRL‐11268) were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin. All cells were maintained at 37°C, 5% CO2 in a humidified incubator.
To induce cellular stress, MEFs were seeded at the required density 24 h prior to treatment. The culture medium was then replaced with fresh medium containing 0.3 μg/ml brefeldin A (Sigma‐Aldrich, B6542), 50 μM etoposide (Sigma‐Aldrich, E1383) or 1 μM paclitaxel (Sigma‐Aldrich, T7402). Chloroquine (Sigma‐Aldrich, C6628) was used at 20 μM. ISRIB (Sigma‐Aldrich, SML0843) was added every 48 h at 200 nM. Spautin‐1 (Sigma‐Aldrich, SML0440) and rapamycin (LC Laboratories, Woburn, MA, USA, R‐500) were added every 24 h at 10 μM and 400 nM, respectively. For γ‐irradiation, cells were trypsinized and kept in suspension during γ‐irradiation (33 Gγ) with a caesium‐137 source (Mainance, Hampshire, UK). Cells were collected by centrifugation at 300 × g for 5 min and then seeded at the required density. For heat shock, cells were trypsinized and resuspended in DMEM into 50 ml tubes, which were immersed completely for 45 min in a preheated water bath with a circulating pump at 43.5 °C. Afterwards, they were pelleted at 300 × g for 10 min, resuspended in fresh DMEM and seeded at required densities.
2.2. Immunoblotting
Cells were lysed in whole cell lysis buffer (100 mM Tris‐HCl pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.1% (w/v) bromophenol blue, 2.5% (v/v) β‐mercaptoethanol). Proteins were separated by SDS‐PAGE and transferred to nitrocellulose membranes (GE Healthcare, Munich, Germany), which were then blocked in 5% (w/v) non‐fat milk dissolved in PBS containing 0.1% (v/v) Tween 20 (Sigma‐Aldrich, P5927). Membranes were probed with specific antibodies against: caspase‐9 (Cell Signaling Technology (CST), Danvers, MA, USA, #9508), FADD (Santa Cruz, Dallas, USA, sc‐6036), cleaved caspase‐8 (CST, #8592), caspase‐8 (CST, #4790), caspase‐3 (CST, #9662), Atg5 (CST, #12994), light‐chain 3 (LC3) (Sigma‐Aldrich, L7543), p‐eIF2α (CST, #3398), eIF2α (CST, #5324), ATF4 (CST, #9508), CHOP (CST, #2895), FLAG (Sigma, F1084) and actin (Sigma‐Aldrich, A2066). Horseradish peroxidase (HRP)–conjugated antibodies were from Jackson ImmunoResearch, Ely, UK: anti‐rabbit (111–035–003), anti‐mouse (115–035–003) and anti‐goat (705–035–003). The signal was visualized using enhanced chemiluminescence reagent (PerkinElmer, Waltham, Massachusetts, USA, NEL102001EA) or ImmunoCruz Luminol Reagent (Santa Cruz, sc‐2048).
2.3. Propidium iodide/ToPro3 staining
Membrane permeability was assessed using propidium iodide (PI) or ToPro3 staining. Briefly, cells were harvested by trypsinization and after 15 min of recovery at 37 °C the cells were resuspended in PBS containing 50 μg/ml PI (Sigma‐Aldrich, P4170) or 1 μM ToPro3 (Thermo Fisher Scientific, Dublin, Ireland T3605). Samples were analysed using a BD Accuri C6 flow cytometer (Becton Dickinson Biosciences) with C flow software V.1.0.264.15.
2.4. shRNA knockdown
Lentivirus for pLKO empty vector, shRNA vector against mouse Casp8 (Sigma‐Aldrich, #TRCN0000012243), pGIPZ empty vector (Open Biosystems, RHS4349) and shRNA vector against mouse Atg5 (Open Biosystems, RMM4431‐99342719) were generated by co‐transfecting plasmids with second‐generation lentivirus packaging system (Addgene, Watertown, Massachusetts, USA, pMD2.G, #12259; psPAX2, #12260; pRSV‐Rev, #12253) using JET PEI transfection reagent (Polyplus‐Transfection, Illkirch, France, #101‐01N) into HEK 293T cells. Virus‐containing supernatants were collected and filtered through 0.22 μm filter. MEFs were transduced in the presence of 5 μg/ml of polybrene (Merck Millipore, Cork, Ireland, TR‐1003‐G). Transduced cells were selected for 72 h in 5 μg/ml of puromycin (Sigma‐Aldrich, P8833) and in 2 μg/ml puromycin for subsequent two passages.
2.5. Immunoprecipitation
Casp9−/− MEFs were seeded at the 3 x 104 cells/cm2 density 24 h prior to the treatment. Boc‐D‐FMK at 20 μM (Cambridge Bioscience, Cambridge, UK, 1160–5) was added 24 h after stress induction to inhibit caspases. Cells were harvested 72 h after stress induction and lysed in 0.5 ml of ice‐cold NP‐40 lysis buffer (150 mM NaCl, 1% NP‐40, 10% glycerol, 10 mM Tris pH 8.0) supplemented with cOmplete™ Mini Protease Inhibitor Cocktail (Roche, Basel, Switzerland, 11836153001). The protein complex was immunoprecipitated using Dynabeads® M‐270 Epoxy (Invitrogen, Carlsbad, CA, USA, Kit number 143.21D) according to the manufacturer's instructions. Briefly, 1 mg of Dynabeads was conjugated to anti‐FADD (Santa Cruz, sc‐6036), anti‐ATG5 (CST, 8540) antibody, goat IgG control (Santa Cruz, sc‐2028) or rabbit IgG (Jackson ImmunoResearch, Ely, UK, 011‐000‐003) overnight at 4 °C. Dynabeads were washed in ice‐cold NP‐40 lysis buffer and combined with cell lysates on a rotor at 4 °C for 4 h. Following the incubation, the beads were washed and 50 μl of elution buffer was added. Beads were rotated at 4 °C for 5 min and precipitated on a magnet. The supernatants were transferred to fresh microfuge tubes and diluted in 50 μl of 2X sample buffer (4% (w/v) SDS, 120 mM Tris‐HCl, 10% (v/v) glycerol, 100 mM DTT and bromophenol blue).
2.6. siRNA transfection
ON‐TARGET plus SMART pool siRNA against mouse Atf4 (Dharmacon, Lafayette, Colorado, USA, L‐042737‐01‐0005), DDit3 (CHOP) (Dharmacon, L‐062068‐00‐0005) and a non‐targeting control (Dharmacon, D‐001810‐10‐20) were resuspended in 1X RNase buffer (60 mM KCl, 6 mM HEPES pH 7.5, 0.5 mM MgCl2), aliquoted and stored at −80 °C. MEFs were transfected with 20 nM of Atf4 siRNA and 25 nM DDit3 siRNA using DharmaFECT1 transfection reagent (Dharmacon, T‐2001‐01). The RNA‐DharmaFECT1 complexes were incubated at room temperature for 20 min. The complexes were added drop wise to the cells and incubated for 5 h at 37 °C. Media was changed, and 24 h later, cells were used for experiments.
2.7. cFLIP overexpression
The MEFs were transfected with a pME18S‐Flag vector containing a CDS for mouse cFLIP long isoform (kindly provided by Prof Kazuhiro Sakamaki, Kyoto University, Japan) using Lipofectamine 3000 transfection reagent (Thermo Fisher, #L3000008) at DNA‐to‐lipid ratio of 1:2. The media was removed 6 h after transfection. Transfected cells were allowed to recover for 24 h prior to any additional treatment. For heat shock treatment and γ‐irradiation exposure, cells were treated, seeded, let to recover for 4 h and followed with transfection with Lipofectamine 3000 which was performed as described above.
2.8. Protein‐protein docking
Human FADD Death Domain (PDB: 1E3Y) and human ATG5‐ATG12 complex (PDB: 4GDK) were prepared using Maestro Schrodinger (Schrödinger Release 2020‐4: Maestro, Schrödinger, LLC, New York, NY, 2020). Protein‐protein docking was performed using webservers PatchDock15 for protein‐protein docking and FireDock16 for flexible protein refinement and scoring of the obtained protein complexes. No constraints were applied on the proteins. The best poses were selected based on the lowest docking score. The HADDOCK protein‐protein docking webserver17 was used as a non‐blind docking approach to investigate FADD and caspase‐8 interaction. Amino acid described by Hughes and collaborators were in this case selected as constraints for the protein‐protein docking.18
2.9. Molecular dynamics simulation
Desmond molecular dynamic (MD) simulation engine19 was used to investigate how the FADD Death Domain behaved over the time in the ATG5‐ATG12 complex. The OPLS3e force field was used.20 Complex solvation was performed using TIP3P water models21 positioned in a cubic box extending 10 Å from nearest protein atom. Na+ and Cl− ions were added to balance the system charge and to obtain a final physiological concentration of 150 mM of NaCl. The temperature and the pressure were kept constant at 300 K and 1 atmosphere, respectively. The simulations were run in triplicate for 100 ns under periodic boundary conditions.
2.10. Residue scanning
Residue hot spots were identified using Schrodinger‐BioLuminate residue scanning calculation.22 Mutated residues inducing the largest change in protein binding affinity (ΔAffinity, in kcal/mol) indicated that they have a significant contribution to the interaction between FADD and ATG5‐ATG12.
2.11. Statistical analysis
Images are representative of at least three independent experiments. Graphs show an average of at least three biological repeats. Error bars represent standard error of mean (SEM). Significance was determined using two‐way ANOVA, with p value <0.05 being considered significant and annotated by *.
3. RESULTS
3.1. Diverse inducers of cell stress activate caspase‐3 in Casp9−/− MEFs in a manner that is dependent on caspase‐8 and ATG5
We previously reported that prolonged ER stress induced by thapsigargin (Tg) or tunicamycin (Tm) leads to processing of pro‐caspase‐8 and pro‐caspase‐3 in Casp9 −/− MEFs.10 Here, we investigated whether ER stress (BFA), DNA damage (etoposide and γ‐irradiation), microtubule stabilization (paclitaxel) and heat shock could similarly activate caspase‐8 in the absence of caspase‐9 (Figure 1A). We observed that all treatments increased the levels of the cleaved form of caspase‐8 and of caspase‐3 (Figure 1B) and induction of cell death, albeit with slower kinetics than for Casp9 +/+ MEFs (Figure S1).
We have also previously reported that ER stress‐induced caspase‐3 processing in Casp9 −/− MEFs is dependent on caspase‐8 and ATG5.10 Here, shRNA‐mediated silencing of caspase‐8 in Casp9 −/− MEFs resulted in a reduction in pro‐caspase‐3 processing in response to BFA, etoposide, paclitaxel or subjected cells to γ‐irradiation and heat shock (Figure 1C). Similarly, we knocked down ATG5 in Casp9 −/− MEFs and treated cells with diverse stressors. shRNA‐mediated silencing of ATG5 produced a large reduction in the ATG5‐ATG12‐conjugated protein, the most abundant form of cellular ATG523 (Figure 1D). In control cells (empty vector), stress stimuli led to an increase in the levels of ATG5‐ATG12 and also increased the processing of pro‐caspase‐8 (Figure 1D). By contrast, in shAtg5 MEFs, there was almost complete inhibition of pro‐caspase‐8 (and pro‐caspase‐3) processing, indicating a requirement for ATG5 in caspase‐8 and caspase‐3 activation under diverse stresses (Figure 1D).
3.2. Stressosome formation is a common event in Casp9−/− MEFs upon induction of cell death with diverse stimuli
We next assessed whether formation of the stressosome complex, containing pro‐caspase‐8, ATG5 and FADD,10 occurred with different stress stimuli. Immunoprecipitation of Casp9 −/− MEF lysates with anti‐FADD (etoposide, paclitaxel, γ‐IR and heat shock) or anti‐ATG5 (BFA) antibodies revealed co‐precipitation of pro‐caspase‐8, ATG5‐ATG12 and FADD (Figure 2A‐D, Figure S2), indicating that stressosome formation is a common event in Casp9 −/− MEFs irrespective of the initiating stress stimulus.
3.3. Computational modelling indicates how the stressosome components interact
Protein docking studies were then used to identify the mode of interactions between stressosome components. We undertook a blind protein‐protein docking approach using PatchDock and FireDock webservers to predict the best docking complex between human ATG5‐ATG12 (PDB:4GDK) and FADD DD (PDB:1E3Y). The pose with the lowest docking score (−6.85 kcal/mol) was further validated by 100 ns MD simulation. Residue scanning predicts that the FADD DD binds to ATG5‐ATG12 through several points of interaction with both ATG5 and ATG12 components of the conjugated protein (Figure 3A). The main residues involved in the interaction are indicated in Figure 3A. Root‐mean‐square deviation (RMSD) and root‐mean‐square fluctuation (RMSF) results show that the complex remains stable (Figure 3B,C). Next, we identified the interaction pose between pro‐caspase‐8 DEDs (PDB:5L08) and full‐length FADD (PDB:2GF5). We performed a non‐blind protein‐protein docking using amino acids 2–13 and 40–51 in the pro‐caspase‐8 DED1 pocket and the F25/L26 motif in the DED domain of FADD, as described previously18 (Figure 3A). Further, we superposed the pro‐caspase‐8 DED/FADD complex with the previous FADD DD/ATG5‐ATG12 complex to obtain the merged stressosome core components (Figure 3A). MD simulations performed in triplicate show that the complex is stable. Despite the large fluctuations in RMSD, mostly due to flexibility between DED and DD domains of FADD and between DED1 and DED2 of pro‐caspase‐8, the RMSF results show that all proteins remain in interaction within the complex (Figure 3D,E).
3.4. Lack of dependence of caspase‐8 activation on autophagy or the integrated stress response
We next investigated whether stressosome formation is dependent on autophagy. Treatment of Casp9 −/− MEFs with BFA, etoposide or paclitaxel triggered autophagic flux as determined by conversion of LC3‐I to the lipidated LC3‐II form in the presence of the lysosomal inhibitor chloroquine (Figure 4A). Inhibition of ATG5‐ATG12 recruitment to the pre‐autophagosomal structures using Spautin‐124 did not affect the kinetics or extent of caspase‐8 and caspase‐3 processing (Figure 4B), while it was effective in reducing LC3 conversion in response to BFA, etoposide and paclitaxel (Figure 4B) to the similar extent as knockdown of Atg5 (Figure S3). These data suggest that while components of the autophagy pathway are involved in stressosome complex formation autophagy itself is not essential for caspase activation.
The ISR is activated by an array of diverse stress stimuli and can ultimately lead to caspase activation and cell death.25 Indeed, we observed that treatment of Casp9 −/− MEFs with BFA, etoposide, paclitaxel and γ‐irradiation induced phosphorylation of eIF2α, expression of ATF4 and CHOP, the core components of ISR signalling (Figure 5A). To assess a potential role for the ISR in activation of caspase‐8, we used pharmacological and genetic approaches to inhibit ISR signalling. We found that inhibition of the ISR using ISRIB26 reduced expression of ATF4 but did not affect activation of caspase‐8 and −3 by BFA, etoposide or paclitaxel (Figure 5B). Knockdown of Atf4 (Figure 5C) or Ddit3 (Figure 5D) in Casp9 −/− MEFs also did not affect processing of caspase‐8 and caspase‐3 induced by indicated stressors. Together our data suggest that the ISR does not contribute to the downstream activation of caspases.
3.5. Effect of caspase‐8 and ATG5 knockdown on cell death induction by various stressors
Due to the role of caspases in apoptosis, we next examined whether stressosome‐dependent caspase‐8 activation mediates the cell death observed upon exposure of Casp9 −/− MEFs to various stresses (Fig. S1). We knocked down caspase‐8 or ATG5 to analyse cell death via PI uptake and long‐term survival by looking at colony formation. While knockdown of Casp8 significantly reduced cell death due to BFA, γ‐irradiation, heat shock and a small extent paclitaxel, it did not affect cell death induced by etoposide (Figure 6A). Atg5 knockdown cells displayed reduced sensitivity to cell death induced by BFA, etoposide and heat shock but similar sensitivity to cell death induced by paclitaxel and γ‐irradiation as control counterparts (Figure 6B). We also observed that, upon depletion of caspase‐8 or ATG5, more colonies were formed following BFA and heat‐shock treatments (Figure 6C). A comparable number of Casp8 or Atg5 knockdown cells and control cells survived paclitaxel treatment and exposure to γ‐irradiation, but they did not form colonies due to the primary inhibitory effect of these treatments on proliferation (Figure 6C). Following treatment with etoposide, there was no long‐term survival of cells.
3.6. Stressosome‐mediated caspase‐8 activation is regulated by cFLIPL
The molecular model (Figure 3A) indicated that cFLIP could prevent caspase‐8 activation within the stressosome complex by interacting with the α1/α4 helices of caspase‐8 DED2, thereby blocking filament formation or, alternatively, by direct binding to FADD DED instead of caspase‐8. To test this, we overexpressed FLAG‐tagged the long form of cFLIP (cFLIPL) in Casp9 −/− MEFs (Figure 7A) and showed that cFLIPL‐overexpressing cells displayed reduced processing of pro‐caspase‐8 and pro‐caspase‐3 following treatment with BFA, etoposide, paclitaxel or exposure to γ‐irradiation or heat shock compared to empty vector counterparts (Figure 7B). cFLIPL was also able to reduce cell death in response to BFA, paclitaxel and heat shock but not in response to etoposide or γ‐irradiation (Figure 7C).
4. DISCUSSION
Here, we demonstrate that diverse cellular stresses can lead to the formation of an alternative caspase‐8‐activating platform, which we have termed the stressosome. Formation of this complex is unmasked when the intrinsic apoptosis pathway is blocked.
Molecular docking supports a model of the stressosome in which pro‐caspase‐8 interacts with FADD through their respective DEDs, and in which the DD of FADD has several points of interaction with both ATG5 and ATG12. However, the model does not explain how multiple pro‐caspase‐8 molecules attain suitable close proximity in the stressosome for auto‐activation. One possibility is that the stressosome forms on autophagosomal membranes through an interaction between ATG5‐ATG12 and ATG16L. Based on the model, ATG5‐ATG12 bound to FADD would be physically available for interaction with dimeric ATG16L.27 This suggests that ATG5‐ATG12:ATG16L complex localized on pre‐autophagosomal structures might serve as a platform for stressosome assembly. In support of this, some groups have reported the involvement of pre‐autophagosomal membranes in ATG5‐mediated activation of caspase‐8.3, 12, 13 Young and colleagues showed that pro‐caspase‐8 forms a complex with ATG5 and FADD on ATG16L‐ and LC3‐positive autophagosomal membranes in cells proficient in apoptosis.3, 9 However, in our experiments, inhibition of autophagosome formation did not reduce pro‐caspase‐8 processing and reduced caspase‐8 activation was observed only in the absence of ATG5 (Figure 4). These findings indicate that the autophagic conjugation machinery but not autophagosomes are required for caspase‐8 activation and that ATG5‐mediated autophagosome elongation and stressosome formation occur independently of each other.
A number of reports suggest that caspase‐8 activation might require DR5 upregulation in response to ER stress,14, 28, 29, 30 but this may not be a universal feature of ER stress.31 The DR5 upregulation is driven by CHOP through the ISR signalling.14 In our experiments, we did not observe a role for the ISR in pro‐caspase‐8 processing.
One intriguing observation from our data is that while different stress stimuli lead to stressosome formation and caspase activation, cell death induction was not universally a consequence of stressosome formation. One explanation may be that stressosome‐dependent caspase activation in certain scenarios could initiate other downstream signalling pathways. It has been reported previously that caspase‐8 has additional, non‐apoptotic functions such as regulation of tumour cell motility, regulation of the inflammasome and cleavage of inflammatory interleukin‐1β.32, 33 Therefore, it is possible that formation of the stressosome and consequent activation of caspase‐8 could lead to inflammatory signalling rather than cell death, depending on the nature of the stimulus.
Resistance to apoptosis is a hallmark of cancer.34 Certain cancers express high levels of anti‐apoptotic proteins such as anti‐apoptotic Bcl‐2 family members or cFLIP or conversely exhibit loss of caspase‐9 and Apaf‐1.35, 36, 37, 38 Such cells frequently exhibit reduced or delayed cell death when exposed to chemotherapeutic drugs. Based on our findings, we suggest that stimulation of stressosome formation could circumvent the chemoresistance and make those cells more sensitive to treatment. For example, our data suggest that targeting cFLIPL may be a strategy to sensitize cells to stressosome‐mediated cell death. cFLIPL is frequently overexpressed in solid tumours and haematological cancers, and its high expression correlates with poor prognosis,38 and several approaches are under development to prevent caspase‐8 interaction with cFLIPL.38, 39
In conclusion, these findings highlight that cells resistant to intrinsic apoptosis can use alternative pathways to activate caspases. The stressosome complex, which consists of ATG5‐ATG12:FADD:pro‐caspase‐8, is formed in response to diverse stresses. Formation of the complex is independent of the ISR, while its activity can be blocked by cFLIPL. The full implications of this to cellular outcomes in cancer remain to be elucidated as caspase‐8 activation is involved in several cellular processes including cell death and inflammatory responses. However, having delineated the stressosome components and pathways regulating stressosome assembly may offer new targets to bypass chemoresistance in cancer.
CONFLICT OF INTEREST
A.M.G., L.A.E. and A.S. are co‐founders and directors at Cell Stress Discoveries Ltd. They declare no conflict of interest.
AUTHOR CONTRIBUTION
Katarzyna Mnich: Formal analysis (equal); Investigation (equal); Visualization (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Izabela Koryga: Formal analysis (equal); Investigation (equal); Writing‐review & editing (equal). Karolina Pakos‐Zebrucka: Formal analysis (equal); Investigation (equal); Methodology (equal). Melissa Thomas: Formal analysis (equal); Investigation (equal); Methodology (equal); Writing‐review & editing (equal). Susan Logue: Formal analysis (equal); Funding acquisition (supporting); Investigation (equal); Writing‐review & editing (equal). Leif Eriksson: Conceptualization (equal); Supervision (equal); Writing‐review & editing (equal). Adrienne M Gorman: Conceptualization (equal); Funding acquisition (lead); Project administration (equal); Supervision (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Afshin Samali: Conceptualization (lead); Funding acquisition (lead); Project administration (equal); Resources (equal); Supervision (equal); Writing‐review & editing (equal).
Supporting information
ACKNOWLEDGEMENTS
Flow cytometry experiments were performed in the NUI Galway Flow Cytometry Core Facility which is supported by funds from NUI Galway, Science Foundation Ireland, the Irish Government’s Programme for Research in Third Level Institutions, Cycle 5 and the European Regional Development Fund. We thank Prof. Tak Mak (University of Toronto, Canada) for providing us with Casp9‐/‐ and matched Casp9+/+‐ MEFs. The Swedish National Infrastructure for Computing (SNIC) is gratefully acknowledged for grants of computing time at supercomputing centres C3SE and PDC, in part funded by the Swedish Research Council through grant agreement no. 2018‐05973. This work was funded by Precision Oncology Ireland, which is part funded by the Science Foundation Ireland (SFI) Strategic Partnership Programme (grant number 18/SPP/3522), an SFI Research Centre grant (CÚRAM, grant number 13/RC/2073_P2), SFI SIRG award (#15/SIRG/3528); SFI Industry Fellowship (18/IF/6247), EU H2020 MSCA RISE‐734749 (INSPIRED), the Sven and Lily Lawski Foundation (to M.T.), the Swedish Research Council (grant no. 2019‐3684, to L.A.E.), and the Canada Research Chairs programme (to S.L). IK received a graduate scholarship from the Irish Research Council (GOIPG/2014/508).
Mnich K, Koryga I, Pakos‐Zebrucka K, et al. The stressosome, a caspase‐8 activating signalling complex assembled in response to cell stress in an ATG5‐mediated manner. J Cell Mol Med. 2021;25:8809–8820. 10.1111/jcmm.16840
Data Availability Statement
Data available on reasonable request from the authors.
REFERENCES
- 1.Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD‐homologous ICE/CED‐3‐like protease, is recruited to the CD95 (Fas/APO‐1) death‐inducing signaling complex. Cell. 1996;85:817‐827. [DOI] [PubMed] [Google Scholar]
- 2.Uzunparmak B, Gao M, Lindemann A, et al. Caspase‐8 Loss Radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis. JCI Insight. 2020;5:e139837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Young MM, Takahashi Y, Khan O, et al. Autophagosomal membrane serves as platform for intracellular death‐inducing signaling complex (IDISC)‐mediated caspase‐8 activation and apoptosis. J Biol Chem. 2012;287:12455‐12468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fianco G, Contadini C, Ferri A, et al. Caspase‐8: a novel target to overcome resistance to chemotherapy in glioblastoma. Int J Mol Sci. 2018;19:3798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fianco G, Mongiardi MP, Levi A, et al. Caspase‐8 contributes to angiogenesis and chemotherapy resistance in glioblastoma. Elife. 2017;6:e22593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Keller N, Ozmadenci D, Ichim G, et al. Caspase‐8 function, and phosphorylation, in cell migration. Semin Cell Dev Biol. 2018;82:105‐117. [DOI] [PubMed] [Google Scholar]
- 7.Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase‐8 mutations lead to human immunodeficiency. Nature. 2002;419:395‐399. [DOI] [PubMed] [Google Scholar]
- 8.Riley JS, Malik A, Holohan C, et al. DED or alive: assembly and regulation of the death effector domain complexes. Cell Death and Dis. 2015;6:e1866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bell BD, Leverrier S, Weist BM, et al. FADD and caspase‐8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A. 2008;105:16677‐16682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Deegan S, Saveljeva S, Logue SE, et al. Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions. Autophagy. 2014;10:1921‐1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Henry CM, Martin SJ. Caspase‐8 acts in a non‐enzymatic role as a scaffold for assembly of a pro‐inflammatory “FADDosome” complex upon TRAIL stimulation. Mol Cell. 2017;65:715‐729.e5. [DOI] [PubMed] [Google Scholar]
- 12.Tang Z, Takahashi Y, Chen C, et al. Atg2A/B deficiency switches cytoprotective autophagy to non‐canonical caspase‐8 activation and apoptosis. Cell Death Differ. 2017;24:2127‐2138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hattori T, Takahashi Y, Chen L, et al. Targeting the ESCRT‐III component CHMP2A for noncanonical caspase‐8 activation on autophagosomal membranes. Cell Death Differ. 2020;28:657‐670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lu M, Lawrence DA, Marsters S, et al. Opposing unfolded‐protein‐response signals converge on death receptor 5 to control apoptosis. Science. 2014;345:98‐101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Schneidman‐Duhovny D, Inbar Y, Nussinov R, et al. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005;33:W363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Andrusier N, Nussinov R, Wolfson HJ. FireDock: Fast interaction refinement in molecular docking. Proteins Struct. Funct. Bioinforma. 2007;69:139‐159. [DOI] [PubMed] [Google Scholar]
- 17.Van Zundert GCP, Rodrigues JPGLM, Trellet M, et al. The HADDOCK2.2 web server: user‐friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428:720‐725. [DOI] [PubMed] [Google Scholar]
- 18.Hughes MA, Powley IR, Jukes‐Jones R, et al. Co‐operative and hierarchical binding of c‐FLIP and caspase‐8: a unified model defines how c‐FLIP isoforms differentially control cell fate. Mol Cell. 2016;61:834‐849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bowers KJ, Chow DE, Xu H, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM/IEEE Conference on Supercomputing 2006, 43.
- 20.Roos K, Wu C, Damm W, et al. OPLS3e: extending force field coverage for drug‐like small molecules. J Chem Theory Comput. 2019;15:1863‐1874. [DOI] [PubMed] [Google Scholar]
- 21.Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926‐935. [Google Scholar]
- 22.Beard H, Cholleti A, Pearlman D, et al. Applying physics‐based scoring to calculate free energies of binding for single amino acid mutations in protein‐protein complexes. PLoS One. 2013;8:82849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ohashi K, Otomo C, Metlagel Z, et al. Structural studies of mammalian autophagy lipidation complex. Methods in Mol Biol. 2019;1880:57‐75. [DOI] [PubMed] [Google Scholar]
- 24.Liu J, Xia H, Kim M, et al. Beclin1 controls the levels of P53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011;147:223‐234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pakos‐Zebrucka K, Koryga I, Mnich K, et al. The integrated stress response. EMBO Rep. 2016;17:1374‐1395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zyryanova AF, Kashiwagi K, Rato C, et al. ISRIB blunts the integrated stress response by allosterically antagonising the inhibitory effect of phosphorylated EIF2 on EIF2B. Mol Cell. 2020;81:88‐103.e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Otomo C, Metlagel Z, Takaesu G, et al. Structure of the human ATG12∼ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol. 2013;20:59‐66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yamaguchi H, Wang HG. CHOP Is Involved in endoplasmic reticulum stress‐induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem. 2004;279:45495‐45502. [DOI] [PubMed] [Google Scholar]
- 29.Lam M, Marsters S, Ashkenazi A, et al. Misfolded proteins bind and activate death receptor 5 to trigger apoptosis during unresolved endoplasmic reticulum stress. Elife. 2020;9:e52291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Iurlaro R, Püschel F, León‐Annicchiarico CL, et al. Glucose deprivation induces ATF4‐mediated apoptosis through TRAIL death receptors. Mol Cell Biol. 2017;37:e00479‐e516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Glab JA, Doerflinger M, Nedeva C, et al. DR5 and caspase‐8 are dispensable in ER stress‐induced apoptosis. Cell Death Differ. 2017;24:944‐950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Feltham R, Vince JE, Lawlor KE. Caspase‐8: not so silently deadly. Clin Transl Immunol. 2017;6:e124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Graf RP, Keller N, Barbero S, Stupack D. Caspase‐8 as a regulator of tumor cell motility. Curr Mol Med. 2014;14:246‐254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57‐70. [DOI] [PubMed] [Google Scholar]
- 35.Fadeel B, Ottosson A, Pervaiz S. Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance. Cell Death Differ. 2008;15:443‐452. [DOI] [PubMed] [Google Scholar]
- 36.Yip KW, Reed JC. Bcl‐2 Family proteins and cancer. Oncogene. 2008;27:6398‐6406. [DOI] [PubMed] [Google Scholar]
- 37.Li P, Zhou L, Zhao T, et al. Caspase‐9: structure, mechanisms and clinical application. Oncotarget. 2017;8:23996‐24008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Humphreys L, Espona‐Fiedler M, Longley DB. FLIP as a therapeutic target in cancer. FEBS J. 2018;285:4104‐4123. [DOI] [PubMed] [Google Scholar]
- 39.Hillert LK, Ivanisenko NV, Busse D, et al. Dissecting DISC regulation via pharmacological targeting of caspase‐8/c‐FLIPL heterodimer. Cell Death Differ. 2020;27:2117‐2130. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data available on reasonable request from the authors.